保體安民注射液

Nazione: Taiwan

Lingua: cinese

Fonte: 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

Principio attivo:

ARGININE HCL L-;;SUCCINATE DISODIUM;;L-ALANINE;;SODIUM SULFATE (EQ TO SODIUM SULPHATE);;L-TYROSINE;;L-ISOLEUCINE;;L-VALINE;;L-SERINE;;HISTIDINE L- HCL (EQ TO L-HISTIDINE HYDROCHLORIDE);;GLUTAMIC ACID L-;;L-PROLINE;;L-THREONINE;;L-LEUCINE;;L-PHENYLALANINE;;SODIUM LACTATE;;SODIUM CITRATE (SODIUM CITRATE TRIBASIC);;GLYCINE (EQ TO AMINOACETIC ACID)(EQ TO GLYCOCOLL);;LYSINE L- HCL ( EQ TO L-LYSINE HCL);;L-TRYPTOPHAN;;L-METHIONINE;;CYSTINE L-;;SODIUM HYDROXIDE;;XYLITOL;;L-ASPARTIC ACID;;XYLITOL

Commercializzato da:

臺田藥品股份有限公司 臺北巿南京東路５段１０８號１１Ｆ (22606538)

Codice ATC:

B05BA01

Forma farmaceutica:

注射劑

Composizione:

SODIUM CITRATE (SODIUM CITRATE TRIBASIC) (4008000800) 20MG; SODIUM LACTATE (4008000900) 138MG; SODIUM SULFATE (EQ TO SODIUM SULPHATE) (4012002200) (DRIED) 30MG; XYLITOL (4020001900) 25000MG; XYLITOL (4020001900) 50.00MG; L-ALANINE (4020100202) 2.17MG; ARGININE HCL L- (4020100312) 3.93MG; L-ASPARTIC ACID (4020100402) 0.53MG; CYSTINE L- (4020100602) 0.06MG; GLUTAMIC ACID L- (4020100702) 0.27MG; HISTIDINE L- HCL (EQ TO L-HISTIDINE HYDROCHLORIDE) (4020100912) 1.87MG; L-ISOLEUCINE (4020101002) 1.58MG; L-LEUCINE (4020101202) 3.01MG; LYSINE L- HCL ( EQ TO L-LYSINE HCL) (4020101312) 2.59MG; L-METHIONINE (4020101502) 1.14MG; L-PHENYLALANINE (4020101702) 2.57MG; L-PROLINE (4020101802) 2.81MG; L-SERINE (4020101902) 1.23MG; L-THREONINE (4020102002) 1.33MG; L-TRYPTOPHAN (4020102102) 0.49MG; L-TYROSINE (4020102202) 0.15MG; L-VALINE (4020102302) 1.82MG; GLYCINE (EQ TO AMINOACETIC ACID)(EQ TO GLYCOCOLL) (4020102400) 4.14MG; SUCCINATE DISODIUM (9500001410) 253MG; SODIUM HYDROXIDE (9600028200) 16MG

Confezione:

瓶裝

Classe:

製　劑

Tipo di ricetta:

限由醫師使用

Prodotto da:

TANABE SEIYAKU CO. LTD. 16-89, KASHIMA 3-CHOME, YODOGAWA-KU, OSAKA, JAPAN2-10 DOSHO-MACHI 3-CHOME, YODOGAWA-KU, OSAKA, JAPAN JP

Area terapeutica:

amino acids

Indicazioni terapeutiche:

不能攝取適當食物之患者之補助治療劑、蛋白質之消化吸收機能及合成利用障礙；嚴重創傷、火傷、骨折時蛋白質之補給、蛋白質攝取減少之營養失調症

Dettagli prodotto:

註銷日期: 2010/09/21; 註銷理由: 屆期未申請展延; 有效日期: 2004/06/15; 英文品名: PROTEAMIN XT INJECTION

Stato dell'autorizzazione:

已註銷

Data dell'autorizzazione:

1999-07-07